Medical Reviewer • Clinical Oversight

Medical Reviewer

This page introduces the licensed medical professional responsible for reviewing clinical content across IvermedX. All ivermectin‑related educational material — including pharmacology, safety, dermatologic applications, and antiparasitic indications — is evaluated for accuracy, clarity, and alignment with established medical knowledge.

Dr. Emily Carter, MD

Board‑Certified Dermatologist & Infectious Disease Specialist

Dr. Emily Carter is a board‑certified U.S. physician specializing in dermatology and infectious diseases — two fields directly relevant to ivermectin’s clinical applications. Her dual‑discipline background provides a balanced perspective on both systemic parasitic infections and dermatologic conditions such as rosacea and Demodex‑associated inflammation.

Dr. Carter’s role at IvermedX is strictly educational. She reviews clinical explanations, pharmacologic descriptions, safety context, and terminology to ensure accuracy and clarity. She does not provide personal medical advice, diagnose conditions, or recommend treatments.

Education & Training

  • MD — University of Michigan Medical School
  • Residency — Dermatology, Mayo Clinic
  • Fellowship — Infectious Diseases, Johns Hopkins Hospital
  • Board Certifications — Dermatology, Infectious Disease Medicine

Clinical Focus Areas

  • Parasitic skin conditions (scabies, lice, Demodex)
  • Inflammatory dermatology (rosacea, perioral dermatitis)
  • Systemic parasitic infections (strongyloidiasis, onchocerciasis)
  • Pharmacology of antiparasitic agents

Role at IvermedX

Dr. Carter ensures that all ivermectin‑related content is:

  • Clinically accurate
  • Clear and accessible to general readers
  • Consistent with established medical knowledge
  • Free from commercial influence
  • Aligned with dermatology and infectious disease guidelines

Her review process follows the standards outlined in the Medical Review Policy.

Reviewer Limitations

The medical reviewer does not provide:

All content reviewed by Dr. Carter is strictly educational and intended to help readers understand ivermectin’s pharmacology, safety, and clinical context.